Discover 2,122 paid clinical trials in Allentown, Pennsylvania. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,122
Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC
for
Hepatocellular Carcinoma, Biliary Tract Cancer
Location: Philadelphia PA, The Bronx NY, Baltimore MD,
Sponsor: Replimune Inc.
Sex: All
Age: 18+
Code: NCT05733598
Phase 2, Recruiting
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
for
Hematologic Malignancies, Inherited Disorders of Metabolism,
Location: Philadelphia PA, Pittsburgh PA, New Brunswick NJ,
Sponsor: Center for International Blood and Marrow Transplant Research
Sex: All
Age: 0+
Code: NCT01351545
Recruiting
Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC
for
Leukemia, Inborn Errors of Metabolism,
Location: Philadelphia PA
Sponsor: Children's Hospital of Philadelphia
Sex: All
Age: 0 - 30
Code: NCT02356653
Early Phase 1, Recruiting
The PERSEVERE Study
for
Pulmonary Embolism, Pulmonary Thromboembolism
Location: Philadelphia PA, New Brunswick NJ, Bay Shore NY,
Sponsor: Inari Medical
Sex: All
Age: 18+
Code: NCT06588634
Recruiting
Azithromycin Prophylaxis for PRElabor CEsarean DElivery Trial
for
Obstetrical Complications, Labor and Delivery Complication,
Location: Philadelphia PA, New York NY, Providence RI,
Sponsor: The George Washington University Biostatistics Center
Sex: Female
Age: 0+
Code: NCT06605118
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Adaptive Neurostimulation to Restore Sleep in Parkinson's Disease (Aim 2)
for
Parkinson's Disease, Sleep Fragmentation
Location: Philadelphia PA, Omaha NE
Sponsor: University of Nebraska
Sex: All
Age: 18 - 70+
Code: NCT05070013
Recruiting
Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer
for
Advanced Breast Cancer
Location: Philadelphia PA, Camden NJ, Hershey PA, New York NY,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06380751
Phase 3, Recruiting
TSC Biosample Repository and Natural History Database
for
Tuberous Sclerosis, Lymphangioleiomyomatosis
Location: Philadelphia PA, New York NY, Silver Spring MD,
Sponsor: National Tuberous Sclerosis Association
Sex: All
Age: 0+
Code: NCT05676099
Recruiting
Get ActivE Study for At-risk Youth
for
Anhedonia, Depression and Suicide Ideation
Location: Philadelphia PA, Pittsburgh PA
Sponsor: University of Pittsburgh
Sex: All
Age: 12 - 18
Code: NCT06829953
Recruiting
Study of Circular RNA Treatment in Patients With Radiation Induced Xerostomia-1
for
Radiation-Induced Xerostomia and Hyposalivation
Location: Philadelphia PA, New York NY, Baltimore MD,
Sponsor: RiboX Therapeutics Ltd.
Sex: All
Age: 18+
Code: NCT06714253
Phase 1, Phase 2, Recruiting
Biliary Atresia Study in Infants and Children
for
Biliary Atresia
Location: Philadelphia PA, Cincinnati OH, Chicago IL, Atlanta GA,
Sponsor: Arbor Research Collaborative for Health
Sex: All
Age: 0 - 20
Code: NCT00345553
Recruiting
CRS Questionnaire Validation Project
for
Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps
Location: Philadelphia PA, Boston MA, Virginia City VA, Toronto,
Sponsor: The European Forum for Research and Education in Allergy and Airway Diseases
Sex: All
Age: 18+
Code: NCT06970977
Recruiting
A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)
Location: Philadelphia PA, Madison WI, Miami FL, Dallas TX,
Sponsor: BlueRock Therapeutics
Sex: All
Age: 18+
Code: NCT06789445
Phase 1, Phase 2, Recruiting
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML